scholarly journals Rap1 and its effector RIAM are required for lymphocyte trafficking

Blood ◽  
2015 ◽  
Vol 126 (25) ◽  
pp. 2695-2703 ◽  
Author(s):  
Wenjuan Su ◽  
Joseph Wynne ◽  
Elaine M. Pinheiro ◽  
Marianne Strazza ◽  
Adam Mor ◽  
...  

Key Points Rap1 and its effector RIAM are required for integrin-mediated T-cell adhesion and homing to lymph nodes, but not for T-cell development. RIAM regulates the activation of lymphocyte function-associated antigen 1 and very late antigen 4 on lymphocytes, but not αIIbβ3 on platelets.

Blood ◽  
2015 ◽  
Vol 126 (4) ◽  
pp. 504-507 ◽  
Author(s):  
Sabrina Geisberger ◽  
Ulrike Maschke ◽  
Matthias Gebhardt ◽  
Markus Kleinewietfeld ◽  
Arndt Manzel ◽  
...  

Key Points PRR deletion in T cells drastically reduces the number of peripheral and thymic CD3+ T cells. We identify multiple stages of thymocyte development that require PRR expression.


1992 ◽  
Vol 103 (1) ◽  
pp. 259-266
Author(s):  
K.L. Sung ◽  
P. Kuhlman ◽  
F. Maldonado ◽  
B.A. Lollo ◽  
S. Chien ◽  
...  

Little is known in quantitative terms about forces between cells generated during adhesion and recognition, or about the contribution of any one set of molecular associations to the development of these forces. To determine the forces involved in adhesion dependent on lymphocyte function-associated antigen-1 (LFA-1) and intercellular adhesion molecule 1 (ICAM-1), we have measured the junctional avidity between single cell pairs consisting of a cloned T cell that expresses LFA-1 and a fibroblast cell that expresses MHC class II molecules and ICAM-1 after transfection. Micromanipulation was used to induce conjugation of cell pairs and to determine the force required to separate the conjugate. T cell adhesion to three related fibroblast cell lines was compared: the parent line that does not express ICAM-1 or other LFA-1 counter-receptors, and two transfectants that have high and moderate levels of surface ICAM-1 expression. The force needed to separate the conjugates varied with the fibroblast ICAM-1 expression levels. The T cell adhesion to ICAM-1-expressing fibroblasts was strong, and the critical separation stresses measured for the three cell lines were 1.4 × 10(3) dyn/cm2 (1 dyn=10(−5) N) for the ICAM-1-negative fibroblast, 4.98 × 10(3) dyn/cm2 for the fibroblast with a moderate level of ICAM-1 expression, and 6.25 × 10(3) dyn/cm2 for the fibroblast line with the highest ICAM-1 expression. The dependence of adhesion strength on the LFA-1/ICAM-1 complex was confirmed by the use of blocking antibodies, which showed the contribution from the interaction of CD4/MHC class II to be negligible.


Blood ◽  
2018 ◽  
Vol 132 (12) ◽  
pp. 1279-1292 ◽  
Author(s):  
Qing Wang ◽  
Ran Yan ◽  
Nancy Pinnell ◽  
Anna C. McCarter ◽  
Yeonjoo Oh ◽  
...  

Key Points Notch1 cofactor Zmiz1 induces a subset of Notch target genes and drives pre–T-cell proliferation during normal and stress thymopoiesis. Disrupting the Zmiz1-Notch1 protein-protein interaction impairs Myc induction, pre–T-cell expansion, and leukemic proliferation.


Blood ◽  
2018 ◽  
Vol 132 (3) ◽  
pp. 281-292 ◽  
Author(s):  
L. M. Ott de Bruin ◽  
M. Bosticardo ◽  
A. Barbieri ◽  
S. G. Lin ◽  
J. H. Rowe ◽  
...  

Key PointsMice with hypomorphic mutations in the Rag1 C-terminal domain are a model of leaky combined immunodeficiency with autoantibodies. Hypomorphic C-terminal domain Rag1 mutations cause repertoire skewing at the earliest stages of B- and T-cell development.


Blood ◽  
2015 ◽  
Vol 126 (14) ◽  
pp. 1658-1669 ◽  
Author(s):  
Sebastian Fuchs ◽  
Anne Rensing-Ehl ◽  
Ulrich Pannicke ◽  
Myriam R. Lorenz ◽  
Paul Fisch ◽  
...  

Key Points Functional reversion of a germline CARD11 mutation in T cells is associated with the development of Omenn syndrome. Defective thymic T-cell development and peripheral lymphopenia are no prerequisite for the development of Omenn syndrome.


1993 ◽  
Vol 177 (1) ◽  
pp. 185-190 ◽  
Author(s):  
Y van Kooyk ◽  
E van de Wiel-van Kemenade ◽  
P Weder ◽  
R J Huijbens ◽  
C G Figdor

Lymphocyte function-associated antigen 1/intercellular adhesion molecule 1 (LFA-1/ICAM-1)-and very late antigen 4/vascular cell adhesion molecule 1 (VLA-4/VCAM-1)-mediated adhesion of T lymphocytes to endothelial cells (EC) can be regulated by increased expression of ICAM-1 and VCAM-1 upon cytokine treatment of EC, or by activation of the integrin molecules LFA-1 and VLA-4 on T cells. Here, we provide evidence that preferential usage of LFA-1 over VLA-4 is yet another mechanism to control T cell adhesion. We observed that binding of activated T lymphocytes, as opposed to resting T cells, to EC is essentially mediated through LFA-1 and not through VLA-4. VLA-4-mediated adhesion of T cells to EC is only found when LFA-1 is not expressed or not functional, as observed for several T cell leukemia cell lines. These results suggest that LFA-1-mediated adhesion dominates and may downregulate VLA-4-mediated adhesion through an unidentified mechanism.


1996 ◽  
Vol 184 (1) ◽  
pp. 215-228 ◽  
Author(s):  
L Crisa ◽  
V Cirulli ◽  
M H Ellisman ◽  
J K Ishii ◽  
M J Elices ◽  
...  

T cell development in the thymus requires the establishment of stable interactions with cell-selecting elements such as the cortical epithelium followed by a regulated movement of selected progenitors to the medulla. Cell adhesion and migration are mediated by integrins in a number of biological systems though little is known regarding their function in the thymus. We demonstrated previously that immature CD3loCD69lo double positive human thymocytes adhere avidly to FN via the integrin, VLA4. We now demonstrate that the interaction of mature CD3hiCD69hi thymic subsets with FN triggers migration rather than firm adhesion. Migration requires the engagement of VLA4 in cooperation with VLA5 and both receptors regulate the persistence and directionality of movement. While migration capability is linked to maturation state, ligand concentration determines the efficiency of migration. In fact, FN and the alternatively spliced CS1 site are predominant in the thymic medulla, suggesting an instructive role of this ECM protein in vivo. Our studies identify a novel VLA4 and VLA5/FN-mediated pathway likely to be involved in regulating cell traffic between the cortex and medulla of the thymus. Moreover, the data provides evidence that VLA4 exists in at least two functional states at distinct stages of T cell development. While different states of VLA4 activation have been described on cell lines, this represents the first evidence supporting a biological significance for this integrin property.


Blood ◽  
2015 ◽  
Vol 125 (23) ◽  
pp. 3563-3569 ◽  
Author(s):  
Fabien Touzot ◽  
Despina Moshous ◽  
Rita Creidy ◽  
Bénédicte Neven ◽  
Pierre Frange ◽  
...  

Key Points SCID-X1 patients treated with gene therapy show faster T-cell development compared with patients treated with haploidentical HSCT.


Sign in / Sign up

Export Citation Format

Share Document